Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Nov 3;9(11):1605.
doi: 10.3390/biomedicines9111605.

Editorial of Special Issue "Multiple Sclerosis: Diagnosis and Treatment II"

Affiliations
Editorial

Editorial of Special Issue "Multiple Sclerosis: Diagnosis and Treatment II"

Victor M Rivera. Biomedicines. .

Abstract

The special issue on Multiple Sclerosis: Diagnosis and Treatment II, reflects advances and discoveries in the molecular and cellular mechanisms of disease, and novel laboratory techniques providing more sensitivity to diagnostic techninques and the understanding of neuroinflammation. Mitochondrial-mediated apoptosis in isolated peripheral blood mononuclear cells and the role of reactive oxygen species are studied as indicators of activity of MS. In these cells, downregulation of circular and linera RNAs are reported as markers of highly active disease in MS. Progress and importance of Neurofilaments determinations in early diagnosis and as a marker of disease activity, and the analysis of the complex mechanisms and therapeutic potential of Sphingosine-1-phosphate receptor modulator are discussed. Epidemiologic observations from a highly diversified area of the world provide more insights into this important aspect of MS; discussions on the clinical challenges posed by spinal cord involvement in demyelinatind disorders and the latest aspects of pediatric onset MS, complement this fine collection of scientific papers.

Keywords: PBMCs; acetylcholine; biomarkers; child neurology; microRNAs; minority populations; multiple sclerosis; neurofilaments light chain; sphingosine-1-phosphate modulators; spinal cord.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

References

    1. Gatta V., Mengog G., Reale M., Tata A.M. Possible Correlation between Cholinergic System Alterations and Neu-ro/Inflammation. Biomedicines. 2020;8:153. doi: 10.3390/biomedicines8060153. - DOI - PMC - PubMed
    1. De Rasmo D., Ferretta A., Russo S., Ruggieri M., Lasorella P., Paolicelli D., Trojano M., Signorile A. PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels. Biomedicines. 2020;8:85. doi: 10.3390/biomedicines8040085. - DOI - PMC - PubMed
    1. Mercado V., Dongarwar D., Fisher K., Salihu H.M., Hutton G.J., Cuascut F.X. Multiple Sclerosis in a Multi-Ethnic Population in Houston, Texas: A Retrospective Analysis. Biomedicines. 2020;8:534. doi: 10.3390/biomedicines8120534. - DOI - PMC - PubMed
    1. Thompson A., Banwell B.L., Barkhof F., Carroll W.M., Coetzee T., Comi G., Correale J., Fazekas F., Filippi M., Freedman M.S., et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2017;17:162–173. doi: 10.1016/S1474-4422(17)30470-2. - DOI - PubMed
    1. Thebault S., Booth R.A., Freedman M.S. Blood Neurofilament Light Chain: The Neurologist’s Troponin? Biomedicines. 2020;8:523. doi: 10.3390/biomedicines8110523. - DOI - PMC - PubMed

Publication types

LinkOut - more resources